Healthequity Overview
Healthequity Target Price
Analysts' 12-month price predictions for HQY.
Share Price
$112.7
Average Target Price
$115.00
2% upside
2% upside1 analysts in the last 4 months
High: $115 | Low: $115
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-03-25 | Raymond JamesStrong Buy | $115 | 2% upside |  |
| 2024-12-10 | BarringtonAlexander Paris | $112 |  0.6% downside | |
| 2024-09-04 | Deutsche BankGeorge Hill | $103 | 8.6% downside | |
| 2024-06-20 | Wells FargoStan Berenshteyn | $110 | 2.4% downside | |
| 2024-06-04 | KeyBancScott Schoenhaus | $100 | 11.3% downside | |
| 2024-06-04 | Robert W. BairdMark Marcon | $104 | 7.7% downside | |
| 2024-06-03 | BarringtonAlexander Paris | $100 | 11.3% downside | |
| 2024-05-07 | Wells FargoStan Berenshteyn | $105 | 6.8% downside | |
| 2024-04-04 | JMP SecuritiesConstantine Davides | $101 | 10.4% downside | |
| 2024-03-28 | JefferiesGlen Santangelo | $95 | 15.7% downside | |
| 2024-03-20 | BarclaysStephanie Davis | $104 | 7.7% downside | |
| 2024-03-20 | RBC CapitalSean Dodge | $92 | 18.4% downside | |
| 2023-09-21 | Robert W. BairdMark Marcon | $87 | 22.8% downside | |
| 2023-06-06 | Loop Capital MarketsScott Schoenhaus | $85 | 24.6% downside | |
| 2022-12-12 | Raymond James | $85 | 24.6% downside | |
| 2022-12-07 | Guggenheim | $94 | 16.6% downside | |
| 2022-12-07 | Wells Fargo | $101 | 10.4% downside | |
| 2022-12-05 | RBC Capital | $75 | 33.5% downside | |
| 2021-12-14 | Raymond JamesCharles Peters | $70 | 37.9% downside | |
| 2021-07-01 | StephensScott Schoenhaus | $100 | 11.3% downside | |
| 2021-06-08 | Cantor FitzgeraldSteven Halper | $85 | 24.6% downside | |